New Advance in Cellular and Molecular Mechanisms of Autoimmune Disease

Dear Colleagues,

The Special Issue, “New Advance in Research of Autoimmune Diseases”, is focused on the cellular and molecular processes involved in the development and progression of both systemic and organ specific autoimmune diseases.

Autoimmune diseases are complex and heterogeneous disorders, caused by a combination of genetic, environmental, hormonal, and immunological factors. These diseases are characterized by a range of clinical manifestations and immune responses, which result in tissue damage. A better understanding of the mechanisms that cause these diseases is critical to their diagnosis and treatment. This will help identify specific patient groups and lead to more personalized approaches to treatment.

This Special Issue invites clinical and basic research submissions focused on the pathophysiology and molecular mechanisms of organ-specific and systemic autoimmune diseases. It also welcomes articles and reviews on innovative therapeutic approaches.

We welcome submissions of original research (including basic, translational, and clinical research) and review articles that explore the regulation, biological functions, and potential therapies for molecules involved in the immune responses in the context of autoimmune and inflammatory diseases. Potential topics for submission include, but are not limited to:

• Investigation of molecules involved in immune activation and suppression in autoimmune and inflammatory diseases;
• Studies on the functional role of these molecules and/or immune cell populations involvement the development and progression of autoimmune and inflammatory diseases;
• Development of new target-specific interventions for autoimmune and inflammatory disorders

Dr. Paolo Fagone
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• systemic and organ specific autoimmune diseases
• cellular and molecular processes
• immune activation and suppression
• functional role of molecules
• new target-specific interventions
• regulation
• biological functions
• potential therapies